· NJ legislature · 222

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Sponsor

Carol Murphy (D-NJ)

Introduced

2026-02-19

Policy area

Health

Latest action

Introduced, Referred to Assembly Health Committee